LOMECEL-B
Live / Registered — Registered (as of 28 Oct 2025)
What this means for you
Registered since 28 Oct 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90295637
- Registration number
- 8005125
- Mark type
- Stylized text
- Filed
- 03 Nov 2020
- Published for opposition
- 21 Sept 2021
- Registered
- 28 Oct 2025
- Attorney of record
- Bryce J. Maynard
Goods and services
- Class 001 — Chemicals: Medicinal signal cells for scientific and research purposes
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medicinal signal cells for medical and veterinary use; pharmaceutical and veterinary preparations for the treatment of frailty in humans and animals
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Scientific research services involving medicinal stem cells
Owner
- LONGEVERON INC., WILMINGTON, DE, US
- LONGEVERON INC., WILMINGTON, DE, US
- Longeveron LLC, Miami, FL, US
- Longeveron LLC, Miami, FL, US
Prosecution history
- 28 Oct 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Oct 2025 — REGISTERED-PRINCIPAL REGISTER
- 09 Oct 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 Oct 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Oct 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 02 Oct 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Oct 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jun 2025 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jun 2025 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 01 Apr 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 01 Apr 2025 — NON-FINAL ACTION E-MAILED
- 01 Apr 2025 — SU - NON-FINAL ACTION - WRITTEN
- 01 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Nov 2024 — USE AMENDMENT FILED
- 31 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL